Drug intelligence / Profile preview

equilenin

Development stage
Unknown
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular, Vaginal
01

Overview

Equilenin is a naturally occurring steroidal estrogen obtained from the urine of pregnant mares. It is also known as 6,8-didehydroestrone and estra-1,3,5(10),6,8-pentaen-3-ol-17-one. Equilenin is one of the components in conjugated estrogens (brand name Premarin), which are primarily used for hormone therapy in postmenopausal women to treat symptoms such as hot flashes and vaginal dryness. Unlike human estrogens such as estradiol or estrone, equilenin does not affect nitric oxide synthase activity or increase nitric oxide production[1][2][5]. Its mechanism of action involves acting as an agonist at estrogen receptors. Equilenin was the first complex natural product to be fully synthesized in a laboratory setting[7]. Conjugated estrogens containing equilenin have also been used for certain cancers but are associated with adverse effects including increased cancer risk[7].

Brand names
Premarin
Other names
6,8-didehydroestroneestra-1,3,5(10),6,8-pentaen-3-ol-17-oneequilenina
02

Targets

ESR1 (ERα)ESR2 (ERβ)

Beyond the preview

Go deeper on equilenin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on equilenin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call